Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells

Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
Immunity (Impact Factor: 21.56). 06/2010; 32(6):815-27. DOI: 10.1016/j.immuni.2010.06.001
Source: PubMed


Commensal microbes can have a substantial impact on autoimmune disorders, but the underlying molecular and cellular mechanisms remain largely unexplored. We report that autoimmune arthritis was strongly attenuated in the K/BxN mouse model under germ-free (GF) conditions, accompanied by reductions in serum autoantibody titers, splenic autoantibody-secreting cells, germinal centers, and the splenic T helper 17 (Th17) cell population. Neutralization of interleukin-17 prevented arthritis development in specific-pathogen-free K/BxN mice resulting from a direct effect of this cytokine on B cells to inhibit germinal center formation. The systemic deficiencies of the GF animals reflected a loss of Th17 cells from the small intestinal lamina propria. Introduction of a single gut-residing species, segmented filamentous bacteria, into GF animals reinstated the lamina propria Th17 cell compartment and production of autoantibodies, and arthritis rapidly ensued. Thus, a single commensal microbe, via its ability to promote a specific Th cell subset, can drive an autoimmune disease.

1 Follower
40 Reads
  • Source
    • "While there are undoubtedly exceptions, mice from The Jackson Laboratory are largely free of SFB, while most mice from other commercial sources are endemically colonized. SFB has a well-recognized influence on the ontogeny of the mucosal immune system and has been shown to significantly affect several mouse models of both enteric and systemic disease (Denning et al. 2011; Ivanov et al. 2009; Lee et al. 2011; Wu et al. 2010). For a more detailed description of the physiological effects of SFB, readers are referred to a recent review on the topic (Ericsson, Hagan et al. 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Eukaryotic organisms are colonized by rich and dynamic communities of microbes, both internally (e.g., in the gastrointestinal and respiratory tracts) and externally (e.g., on skin and external mucosal surfaces). The vast majority of bacterial microbes reside in the lower gastrointestinal (GI) tract, and it is estimated that the gut of a healthy human is home to some 100 trillion bacteria, roughly an order of magnitude greater than the number of host somatic cells. The development of culture-independent methods to characterize the gut microbiota (GM) has spurred a renewed interest in its role in host health and disease. Indeed, associations have been identified between various changes in the composition of the GM and an extensive list of diseases, both enteric and systemic. Animal models provide a means whereby causal relationships between characteristic differences in the GM and diseases or conditions can be formally tested using genetically identical animals in highly controlled environments. Clearly, the GM and its interactions with the host and myriad environmental factors are exceedingly complex, and it is rare that a single microbial taxon associates with, much less causes, a phenotype with perfect sensitivity and specificity. Moreover, while the exact numbers are the subject of debate, it is well recognized that only a minority of gut bacteria can be successfully cultured ex vivo. Thus, to perform studies investigating causal roles of the GM in animal model phenotypes, researchers need clever techniques to experimentally manipulate the GM of animals, and several ingenious methods of doing so have been developed, each providing its own type of information and with its own set of advantages and drawbacks. The current review will focus on the various means of experimentally manipulating the GM of research animals, drawing attention to the factors that would aid a researcher in selecting an experimental approach, and with an emphasis on mice and rats, the primary model species used to evaluate the contribution of the GM to a disease phenotype. © The Author 2015. Published by Oxford University Press on behalf of the Institute for Laboratory Animal Research. All rights reserved. For permissions, please email:
    ILAR journal / National Research Council, Institute of Laboratory Animal Resources 08/2015; 56(2). DOI:10.1093/ilar/ilv021 · 2.39 Impact Factor
  • Source
    • "For instance, a recent experimental study using an osteomyelitis mice model has shown that diet can modulate the microbiome (high fat diet induces a decrease in Prevotella), which in turn offered protection against inflammatory bone disease (Lukens et al., 2014). Increasing evidence suggests that alteration of the microbiota not only has effects on intestinal conditions such as Crohn's and other Inflammatory Bowel Diseases (Gevers et al., 2014; Morgan et al., 2012), but also in the development of systemic immune diseases such as rheumatoid arthritis (Scher & Abramson, 2011; Wu et al., 2010), type I diabetes (Kriegel et al., 2011; Suez et al., 2014), and allergic diseases (Castro-Nallar et al., in press; Hong et al., 2010; Nakayama et al., 2011; Pérez-Losada et al., 2015). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The role of the human microbiome in schizophrenia remains largely unexplored. The microbiome has been shown to alter brain development and modulate behavior and cognition in animals through gut-brain connections, and research in humans suggests that it may be a modulating factor in many disorders. This study reports findings from a shotgun metagenomic analysis of the oropharyngeal microbiome in 16 individuals with schizophrenia and 16 controls. High-level differences were evident at both the phylum and genus levels, with Proteobacteria, Firmicutes, Bacteroidetes, and Actinobacteria dominating both schizophrenia patients and controls, and Ascomycota being more abundant in schizophrenia patients than controls. Controls were richer in species but less even in their distributions, i.e., dominated by fewer species, as opposed to schizophrenia patients. Lactic acid bacteria were relatively more abundant in schizophrenia, including species of textitLactobacilli and textitBifidobacterium, which have been shown to modulate chronic inflammation. We also found textitEubacterium halii, a lactate-utilizing species. Functionally, the microbiome of schizophrenia patients was characterized by an increased number of metabolic pathways related to metabolite transport systems including siderophores, glutamate, and vitamin B12. In contrast, carbohydrate and lipid pathways and energy metabolism were abundant in controls. These findings suggest that the oropharyngeal microbiome in individuals with schizophrenia is significantly different compared to controls, and that particular microbial species and metabolic pathways differentiate both groups. Confirmation of these findings in larger and more diverse samples, e.g., gut microbiome, will contribute to elucidating potential links between schizophrenia and the human microbiota.
    PeerJ 08/2015; 3(8):e1140. DOI:10.7717/peerj.1140 · 2.11 Impact Factor
    • "A number of microorganisms, including Klebsiella pneumoniae, Proteus mirabilis , and segmented filamentous bacteria (SFB), have been implicated as necessary, and in some cases sufficient (Garrett et al., 2010; Wu et al., 2010). However, although it is well established that IL-17-producing T cells are activated by microbial components in the gut environment (Ivanov et al., 2009; Wu et al., 2010), it is unclear how this relates to activation of tissuespecific autoimmune T cells. The recently published evidence that the Th17 cells elicited by SFB are actually specific to SFB antigens (Goto et al., 2014; Yang et al., 2014) makes the connection to tissue-specific pathology even less clear. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Activated retina-specific T cells that have acquired the ability to break through the blood-retinal barrier are thought to be causally involved in autoimmune uveitis, a major cause of human blindness. It is unclear where these autoreactive T cells first become activated, given that their cognate antigens are sequestered within the immune-privileged eye. We demonstrate in a novel mouse model of spontaneous uveitis that activation of retina-specific T cells is dependent on gut commensal microbiota. Retina-specific T cell activation involved signaling through the autoreactive T cell receptor (TCR) in response to non-cognate antigen in the intestine and was independent of the endogenous retinal autoantigen. Our findings not only have implications for the etiology of human uveitis, but also raise the possibility that activation of autoreactive TCRs by commensal microbes might be a more common trigger of autoimmune diseases than is currently appreciated. Copyright © 2015 Elsevier Inc. All rights reserved.
    Immunity 08/2015; 43(2):343-53. DOI:10.1016/j.immuni.2015.07.014 · 21.56 Impact Factor
Show more


40 Reads
Available from